We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Itaconix Plc | LSE:ITX | London | Ordinary Share | GB00BPK3YZ68 | ORD 50P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 153.00 | 146.00 | 160.00 | 153.00 | 148.00 | 153.00 | 536 | 08:00:26 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Chemicals & Chem Preps, Nec | 5.6M | -2.46M | -0.1826 | -8.38 | 20.63M |
From Apr 2019 to Apr 2024
TIDMITX
RNS Number : 4573C
Itaconix PLC
10 February 2020
10 February 2020
Itaconix plc ("Itaconix" or the "Company")
New BIO*Asterix(TM) Product Line
Itaconix, a leading innovator in sustainable specialty polymers, is pleased to announce its BIO*Asterix(TM) line of functional additives based on a new range of bio-based chemistries derived from itaconic acid. The Company developed the new BIO*Asterix(TM) additives over the past three years for a wide range of potential uses, ranging from biodegradable plastics to decorative paints. The Company plans to launch its new product line in stages over the next two years.
The Company's initial focus will be on targeting the biodegradable plastics market where the new BIO*Asterix additives have had positive results in early field trials with potential customers. The BIO*Asterix additives can add valuable properties or overcome performance deficiencies that currently limit the use of biodegradable plastics.
Dr. Yvon Durant, CTO of Itaconix, stated: "The new BIO*Asterix product line leverages our success at meeting customer needs with our understanding of itaconic acid chemistries. I believe industry and academic researchers will find value both in the unique functionality of the chemistries and in our expertise in realizing the unique value of these products."
John R. Shaw, CEO of Itaconix, added: "BIO*Asterix represents a broad new frontier for Itaconix and the value of itaconic acid chemistries. We are confident from the early success of customer trials that our new BIO*Asterix products will become key additives in numerous applications and generate new revenues in the years to come. We look forward to reporting progress as our efforts advance."
Ends
For further information please contact:
Itaconix +1 (603) 775 4400 John R. Shaw / Laura Denner N+1 Singer +44 (0) 207 496 3000 Peter Steel / James Moat (Corporate Finance) Tom Salvesen (Corporate Broking)
About Itaconix
Itaconix plc is a leading innovator in bio-based functional ingredients for improving the safety and performance of homecare, personal care, and industrial products. Its proprietary polymer technology generates a growing range of new ingredients with unique functionality that meet consumer demands for value and sustainability.
www.itaconix.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
MSCURSNRRKUUARR
(END) Dow Jones Newswires
February 10, 2020 02:00 ET (07:00 GMT)
1 Year Itaconix Chart |
1 Month Itaconix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
